Skip to main content
EVO
NASDAQ Life Sciences

Evotec SE Reports New 5.03% Stake by Michael Kaufman and Triton's Increased Holding to 9.97%

Analysis by Wiseek AI
Sentiment info
Positive
Importance info
8
Price
$3.76
Mkt Cap
$1.339B
52W Low
$2.84
52W High
$4.8
Market data snapshot near publication time

Summary

Evotec SE disclosed two significant ownership changes: Michael Kaufman's entities reported a new 5.03% stake, while Triton GP HoldCo SARL increased its holding to 9.97% from 9.16%.


Key Events

  • Michael Kaufman's Entities Disclose New 5.03% Stake

    Michael Kaufman and associated entities, including MAK Capital Fund LP, reported a new aggregate holding of 5.03% of Evotec SE's voting rights, comprising 2.89% in direct shares and 2.14% through equity swaps. This represents a significant new institutional investment.

  • Triton Increases Stake to 9.97%

    Triton GP HoldCo SARL, a private equity firm and existing major investor, increased its total holding in Evotec SE to 9.97% of voting rights, up from a previously reported 9.16%. The new filing indicates that the entire stake is now held as direct voting rights, suggesting a conversion of prior instrument holdings to direct shares, which demonstrates increased commitment.


Analysis

These filings indicate strong institutional interest and conviction in Evotec SE. The emergence of Michael Kaufman's entities as a new 5.03% shareholder, combining direct shares and equity swaps, signals fresh investor confidence. Concurrently, Triton GP HoldCo SARL, an existing major investor, increased its stake to nearly 10% and appears to have converted previous instrument holdings into direct shares, further solidifying its commitment. Such significant accumulation by institutional investors can be a positive indicator for the company's future prospects.

At the time of this filing, EVO was trading at $3.76 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $2.84 to $4.80. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EVO - Latest Insights

EVO
May 12, 2026, 5:15 PM EDT
Source: Access Newswire
Importance Score:
8
Price at Filing: $3.00
Real-time Price: $2.72 info
Change: -$0.280 (-9%) info
Market Cap: $980.571M info
EVO
May 06, 2026, 9:39 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $3.11
Real-time Price: $2.72 info
Change: -$0.385 (-12%) info
Market Cap: $980.571M info
EVO
May 04, 2026, 1:50 AM EDT
Source: Access Newswire
Importance Score:
8
Price at Filing: $3.09
Real-time Price: $2.72 info
Change: -$0.370 (-12%) info
Market Cap: $980.571M info
EVO
May 01, 2026, 5:01 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $3.09
Real-time Price: $2.72 info
Change: -$0.370 (-12%) info
Market Cap: $980.571M info
EVO
Apr 30, 2026, 11:48 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.06
Real-time Price: $2.72 info
Change: -$0.340 (-11%) info
Market Cap: $980.571M info
EVO
Apr 24, 2026, 6:03 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.07
Real-time Price: $2.72 info
Change: -$0.350 (-11%) info
Market Cap: $980.571M info
EVO
Apr 08, 2026, 11:56 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.70
Real-time Price: $2.72 info
Change: +$0.020 (+0.74%) info
Market Cap: $980.571M info
EVO
Apr 08, 2026, 11:52 AM EDT
Filing Type: 20-F
Importance Score:
8
Price at Filing: $2.70
Real-time Price: $2.72 info
Change: +$0.020 (+0.74%) info
Market Cap: $980.571M info
EVO
Apr 07, 2026, 12:44 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $2.57
Real-time Price: $2.72 info
Change: +$0.1484 (+6%) info
Market Cap: $980.571M info
EVO
Apr 06, 2026, 12:56 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $2.59
Real-time Price: $2.72 info
Change: +$0.1299 (+5%) info
Market Cap: $980.571M info